Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Let's Talk About Our Feelings!!! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (107305)	8/8/2005 2:23:23 AM
From: Grainne	Read Replies (1) \| Respond to of 108807

The original article about the vaccine was full of qualifications--the supply of eggs to make the vaccine may be low, the general production speed is difficult to ramp up, the vaccine has not been tried in really young and old people, etc. And I think it goes without saying that privileged affluent westerners will probably be the only people who get the vaccine. I still think it is better news than not having an effective vaccine. And I am puzzled at something in your report that says the vaccine has to be a very close match to work, and the virus is already significantly mutated, so that won't work. My own unscientific understanding is that somewhat of a match is still somewhat effective. Is that not true at all?